Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M34,250Revenue $M600Net Margin (%)-117.4Altman Z-Score13.5
Enterprise Value $M33,904EPS $-3.0Operating Margin %-108.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score-1.7Pre-tax Margin (%)-117.0Higher ROA y-yN
Price/Book34.910-y EBITDA Growth Rate %--Quick Ratio4.4Cash flow > EarningsY
Price/Sales55.55-y EBITDA Growth Rate %--Current Ratio4.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-31.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-62.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M244ROIC % (ttm)-126.5Gross Margin Increase y-yY

Gurus Latest Trades with VRTX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRTXKen Fisher 2015-06-30 Reduce$116.43 - $135.82
($125.88)
$ 136.999%Reduce 0.18%4,378
VRTXVanguard Health Care Fund 2015-03-31 Reduce-0.08%$107.88 - $134.25
($119.81)
$ 136.9914%Reduce 2.80%9,533,911
VRTXGeorge Soros 2015-03-31 Buy 0.07%$107.88 - $134.25
($119.81)
$ 136.9914%New holding56,912
VRTXKen Fisher 2015-03-31 Add$107.88 - $134.25
($119.81)
$ 136.9914%Add 0.18%4,386
VRTXVanguard Health Care Fund 2014-12-31 Reduce-0.58%$101.1 - $120.78
($112.61)
$ 136.9922%Reduce 16.93%9,808,860
VRTXKen Fisher 2014-09-30 Reduce$84.74 - $113.9
($94.97)
$ 136.9944%Reduce 31.99%4,593
VRTXVanguard Health Care Fund 2014-06-30 Add0.04%$62.44 - $94.68
($70.13)
$ 136.9995%Add 1.54%11,807,500
VRTXGeorge Soros 2014-06-30 Sold Out -0.01%$62.44 - $93.77
($69.73)
$ 136.9996%Sold Out0
VRTXKen Fisher 2014-06-30 Buy $62.44 - $93.77
($69.73)
$ 136.9996%New holding6,753
VRTXVanguard Health Care Fund 2014-03-31 Add0.13%$67.8 - $85.48
($79.08)
$ 136.9973%Add 5.89%11,628,500
VRTXGeorge Soros 2014-03-31 Buy 0.01%$67.8 - $85.48
($79.17)
$ 136.9973%New holding10,000
VRTXVanguard Health Care Fund 2013-12-31 Add0.88%$60.18 - $77.83
($69.45)
$ 136.9997%Add 54.06%10,981,500
VRTXVanguard Health Care Fund 2013-09-30 Add0.29%$74.53 - $88.51
($79.62)
$ 136.9972%Add 19.00%7,127,997
VRTXVanguard Health Care Fund 2013-06-30 Add1.05%$52.6 - $85.6
($73.64)
$ 136.9986%Add 140.58%5,990,000
VRTXNWQ Managers 2013-06-30 Sold Out -0.09%$52.6 - $85.6
($73.64)
$ 136.9986%Sold Out0
VRTXVanguard Health Care Fund 2013-03-31 Add0.05%$43.65 - $54.97
($48.01)
$ 136.99185%Add 10.97%2,489,800
VRTXNWQ Managers 2013-03-31 Reduce-0.02%$41.9 - $54.97
($47.91)
$ 136.99186%Reduce 23.44%191,032
VRTXGeorge Soros 2012-09-30 Sold Out -0.09%$48.38 - $59.07
($53.5)
$ 136.99156%Sold Out0
VRTXJoel Greenblatt 2012-09-30 Sold Out -0.08%$48.38 - $59.07
($53.5)
$ 136.99156%Sold Out0
VRTXNWQ Managers 2012-06-30 Reduce-0.27%$35.75 - $65.62
($50.92)
$ 136.99169%Reduce 83.86%188,842
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRTX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VRTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Silva Paul MSVP & Corp Controller 2015-07-30Sell860$128.967.88view
BOGER JOSHUA SDirector 2015-07-29Sell10,400$126.689.82view
Silva Paul MSVP & Corp Controller 2015-07-27Sell1,125$123.2812.85view
BOGER JOSHUA SDirector 2015-07-22Sell10,400$130.926.26view
BOGER JOSHUA SDirector 2015-07-15Sell12,200$133.983.84view
Silva Paul MSVP & Corp Controller 2015-07-13Sell1,125$123.7912.38view
BOGER JOSHUA SDirector 2015-07-08Sell11,700$122.7413.35view
Chodakewitz JeffreyEVP GMDA, CMO 2015-07-02Sell2,291$129.367.54view
BOGER JOSHUA SDirector 2015-07-01Sell11,700$125.610.76view
BOGER JOSHUA SDirector 2015-06-24Sell11,700$130.416.68view

Quarterly/Annual Reports about VRTX:

News about VRTX:

Articles On GuruFocus.com
Lee Ainslie Adds 90 New Stocks to His Portfolio Within the First Quarter May 20 2015 
Analysts Confident That Vertex Pharmaceuticals' CF Drug Will Receive FDA Approval May 13 2015 
Fate Of Cystic Fibrosis Drug By Vertex Is Now Dependent On FDA Approval May 13 2015 
J.P. Morgan Chimes In With Ratings On BioTech Stocks Jan 06 2015 
William Blair’s Top BioPharmaceutical Stock Picks for Q1 2015 Dec 23 2014 
Weekly CFO Sells Highlight: Texas Instruments Inc, Royal Caribbean Cruises Ltd, Vertex Pharmaceutica Nov 09 2014 
Weekly CFO Sells Highllight: Facebook Inc, Vertex Pharmaceuticals Inc, Nike Inc. Oct 05 2014 
Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells Cerner Corporation, AbbVi Aug 02 2013 
Weekly Guru Bargains Highlights: MBI, VRTX, GRPN, PBI, PC Dec 16 2012 
WEEKLY CFO SELLS HIGHLIGHT: AKRX, FIO, OVRL, VRTX Oct 21 2012 

More From Other Websites
3 Potential Huge Takeover Targets in Biotech Aug 04 2015
Advanced Estimate: US 2Q Gross Domestic Product Expanded by 2.3% Jul 31 2015
Biogen Can Get Growth Spurt It Needs With Vertex Deal: Real M&A Jul 30 2015
Vertex Pharmaceuticals (VRTX) Earnings Report: Q2 2015 Conference Call Transcript Jul 30 2015
Vertex Posts Wider Y/Y Loss but Raises Kalydeco Outlook - Analyst Blog Jul 30 2015
Large-Cap Healthcare Stocks Outperform Small Caps Jul 30 2015
Edited Transcript of VRTX earnings conference call or presentation 29-Jul-15 9:00pm GMT Jul 30 2015
Vertex Reports Second Quarter 2015 Financial Results Jul 29 2015
[$$] Vertex Revenue Rises 20% Jul 29 2015
VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 29 2015
Vertex reports 2Q loss Jul 29 2015
Vertex reports 2Q loss Jul 29 2015
Vertex Reports Second Quarter 2015 Financial Results Jul 29 2015
Q2 2015 Vertex Pharmaceuticals Inc Earnings Release - After Market Close Jul 29 2015
Will Vertex (VRTX) Surprise with a Lower Loss in Q2? - Analyst Blog Jul 28 2015
CRBP: Warrant Exercise To Provide Sufficient Cash Through 2016 Jul 28 2015
What to Watch in the Week Ahead and on Monday, July 27 Jul 24 2015
Will The High Cost Of Vertex's New Cystic Fibrosis Drug Push The U.S. To European Style Pricing? Jul 22 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK